Michael H. Gold, MD; Andrew Korotzer, PhD Michael H. Gold, MD, is from Gold Skin Care Center and Tennessee Clinical Research Center, Nashville, Tennessee; Andrew Korotzer, PhD, is from Valeant
aDana DiBenedetti, PhD; bEileen Baranowski, PharmD*; bSusan Zelt, DrPH†; aMaria Reynolds, MStat; aBeth Sherrill, MS aRTI Health Solutions, Research Triangle Park, North Carolina; bStiefel, A GSK Company, Research Triangle Park,
aGanary Dabiri, MD, PhD; bJeffrey Tiger, MD; cHeidi Anderson, MD; dSatori Iwamoto, MD, PhD aRoger Williams Medical Center/Boston University School of Medicine, Providence, Rhode Island; bLahey Hospital and Medical Center,
a,b,cOrit Markowitz, MD; a,b,cMichelle Schwartz, BA; a,b,cEleanor Feldman, BA; a,b,cAmanda Bienenfeld, BA; a,b,cAmy Kalowitz bieber, BS; c,dJeffery Ellis, MD; b,cUsha Alapati, MD; aMark Lebwohl, MD; b,cDaniel M. Siegel, MD, MS
aBruce E. Katz, MD; bJoseph Lewis, BS; bLaura McHugh, MS; cArthur Pellegrino, BS; cLavinia Popescu, MS, MBA aClinical Professor, Icahn School of Medicine at Mount Sinai, New York, New York;
aRichard R. Winkelmann, DO; bAxel Hauschild, MD; cNatalie Tucker, BS; dRichard White, MS; eDarrell S. Rigel, MD, MS aMelanoma Clinical Research Fellow, National Society for Cutaneous Medicine, New York, New
aEkin Mese Say, MD; bGokhan Okan, MD; cGonca Gökdemir, MD aEyup State Hospital, Istanbul, Turkey; bKemerburgaz University, Dermatology Department, Istanbul, Turkey; cBahcesehir University, Dermatology Department, Turkey Disclosure: The authors report
aRichard R. Winkelmann, DO; bJane Yoo, MD, MPH; cNatalie Tucker, BS; dRichard White, MS; eDarrell S. Rigel MD, MS aMelanoma Clinical Research Fellow, Rigel Dermatology, New York, New York; bMohs
aNeal Bhatia, MD; bRadhakrishnan Pillai, PhD aTherapeutics Clinical Research, San Diego, California; aDow Pharmaceutical Sciences Inc. (a division of Valeant Pharmaceuticals), Petaluma, California Disclosure: Dr. Bhatia is a consultant and/or
aJames H. Herndon, Jr, MD, FAAD; bElizabeth T. Makino, BS, CCRA, MBA; aLily I. Jiang, PhD; aThomas J. Stephens, PhD; bRahul C. Mehta, PhD aThomas J. Stephens & Associates, Richardson,
Guy Webster, MD, PhD Department of Dermatology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania Disclosure: Dr. Webster is a consultant for Janssen, Galderma, and Valeant. Abstract
aJoshua P. Fogelman, MD; bMary L. Stevenson, MD; b,cRobin Ashinoff, MD; bNicholas A. Soter, MD aDepartment of Dermatology, Columbia University, and Dermatology Center of Rockland, P.C., New York, New York,
aIrene Tausch, MD; IlJa Kruglikov, PhD, DrSci aKosmed Clinic, Kiel, Germany; bWellcomet GmbH, Karlsruhe, Germany Disclosure: Dr. Tausch reports no relevant conflicts of interest. Dr. Kruglikov is the managing partner
aDavid Wirta, MD; bDavid M. Pariser, MD; cSteven G. Yoelin, MD; dSeiji Arase, MD; eAmy McMichael, MD; fEmily Weng, ScD; fCheri Mao, MSc; fGeorge Demos, MD*; fAmanda VanDenburgh, PhD aDavid
a,bMichael H. Gold, MD; aJulie A. Biron, BSc; aBrynne Thompson, RN, CCRP aTennessee Clinical Research Center, Nashville, Tennessee; bGold Skin Care Center, Nashville, Tennessee Disclosure: Dr. Gold is a consultant
Moetaz El-Domyati, MD; Manal Barakat, MD; Sherif Awad, MD; Walid Medhat, MD; Hasan El-Fakahany, MD; Hanna Farag, MD Department of Dermatology, Al-Minya University, Al-Minya, Egypt Disclosure: The authors report no
David A. Rodriguez, MD Dermatology Associates/Research, Coral Gables, Florida Disclosure: Dr. Rodriguez has served as a paid consultant to Valeant Pharmaceuticals North America LLC. Abstract Objective: To evaluate efficacy, safety,
Arlene M. Ruiz de Luzuriaga, MD, MPH; Clifford Hsieh, BS Dr. Ruiz is from the University of Chicago, Department of Medicine, Section of Dermatology, Chicago, Illinois. Mr. Hsieh is from
Richard R. Winkelmann, DO; Darrell S. Rigel, MD, MS; Emily Kollmann, DO, MS; Nicole Swenson, DO; Natalie Tucker, BS; Mark S. Nestor. MD, PhD Dr. Winkelmann Rigel Dermatology, New York,
Jerry Brewer, MD; Donna McQuinn, BSN, RN; Christine Lohse, MS; John Hassani, DO, MA Dr. Brewer is from the Mayo Clinic, Department of Dermatology, Rochester Minnesota. Ms. McQuinn and Ms.